AI summary

Tirzepatide batch T30 Orange Cap (Jan 2026) achieved 99.893% purity with consistent results across samples; quantity deviation of 11.2% indicates potential underfill.

Test date
2026-03-24
Purity
99.89% 99.871% - 99.909% (avg. 99.893%)
Batch / lot
T30 Orange Cap January 2026
Lab
JEEP
Quantity
label 30mg tested 33.36mg
Qty vs label
+11.2%
Endotoxins
—
Test score
—
Manufacturer
Guangzhou Jeep Biotechnology Jeep
View vendor dossier
Peptides on this report
Tirzepatide
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Community submission

✓ Artifact captured

We have the certificate image — you can verify it loads from the upstream lab and matches the artifact below.

Dose
30mg
Catalogued
2026-06-13
OCR text

Raw extracted text

Extracted via OCR. Names, emails, phone numbers, and street addresses are auto-redacted before display. 

TEST REPORT
JANOSHIK
E-mail: [EMAIL_REDACTED]
Web: www.janoshik.com
Task Number #124223
Testing ordered > 02 MAR '26
Sample received > 10 MAR '26
Client EPU x LS Group Testing GB x juGGakNot Empire
Sample T1-T8
Manufacturer JEEP
Batch T30 Orange Cap January 2026
Sample description >
See picture or pictures attached.
Tests requested >
Assessment of a peptide vial or vials.
Results >
Tirzepatide 32.72 mg - 35.10 mg (avg. 33.36 [NAME_REDACTED])
Purity 99.871% - 99.909% (avg. 99.893%)
Comments >
Analysis conducted > 24 MAR 2026
Signature >
Verify this test at www.janoshik.com/verify/ with the following unique key
185J83WEPIUE
This COA is part of TitrateLab's community-trust corpus. See more from Guangzhou Jeep Biotechnology Jeep or learn how trust scores are computed on the methodology page.